Anaesth Intensive Care 2017 | 45: 6 Can we reduce the prevalence of persistent opioid use after surgery by predicting the future?
It is well known that there is a continuum of acute to chronic pain and the origin of that pain can sometimes be surgery. A recent editorial 1 in Anaesthesia and Intensive Care highlights that post-surgical acute pain can lead to chronic pain and factors predicting this transition include previous surgery, gender and psychosocial factors. In this issue 2 , Stark et al report on the prevalence of chronic opioid use to manage chronic pain after surgery and explore factors measurable at the time of surgery that might predict who these patients will be. In a cohort of nearly 1,000 opioidnaïve patients awaiting surgical intervention, 10% were using opioids more than 90 days post-surgery, and the surgery type and pre-existing anxiety were among the factors highly predictive of postoperative chronic opioid use. Not surprisingly, they find a positive association between higher levels of pain at follow-up and persistent opioid use at that time. While the overall prevalence of opioid use at 90 days was 10%, the prevalence by surgery type varied from 0% up to 25%. For patients undergoing orthopaedic surgery who were not using opioids prior to surgery, 14% became persistent opioid users 90 days after surgery while nearly one in four spinal surgery patients were new chronic users after 90 days. For other surgeries such as gastrointestinal surgery, only 5% were persistent opioid users after 90 days. Looking at the data another way, orthopaedic and spinal surgery accounted for over 50% of the surgery cases studied but accounted for over 90% of chronic opioid users.
In the study by Stark et al 2 , only opioid-naïve patients were included, however, this group account for only half of all patients receiving orthopaedic surgery and only 35% of spinal surgery patients. The issue of persistent chronic opioid use in patients who were already using opioids prior to surgery is another important issue. The indication for total hip or total knee orthopaedic surgery is often osteoarthritis which is a painful condition often treated with opioids prior to surgery. A study of Australian patients undergoing total hip orthopaedic surgery found that persistent opioid use after surgery is prevalent not only in those who are opioid-naïve at the time of surgery but also in those who were using opioids prior to surgery. The study found that 5% of patients were chronic users of opioids after surgery; 60% of these patients were chronic users prior to surgery and 40% were new chronic users 3 .
The current study by Stark et al recommends that identification of high-risk patients could provide an opportunity for targeted pre-and postoperative interventions that may reduce the risk of long-term opioid use 2 . They identified that chronic opioid use was more likely in patients undergoing spinal or orthopaedic surgery and in those with pre-existing anxiety at the time of their surgery. Anxiety and catastrophising have been identified in other studies as important risk factors for chronic opioid use, including post-surgical use [4] [5] [6] [7] [8] . Stark et al recommend that pre-admission clinics could assist in the identification of high-risk patients; however, their results, which suggest that attendance at a pre-admission clinic was actually associated with chronic opioid use, appear counterintuitive. This result is actually more likely to reflect the attendance at pre-admission clinics by the more complex or serious cases in this study, and perhaps a lack of focus on risk of development of chronic opioid use. Future work could examine the effect of an opioid risk screening intervention which includes use of catastrophising scales and assessment of anxiety at pre-surgical admission clinics. While opioid risk screening tools exist 9-11 they have generally been developed among cohorts of patients attending pain clinics; their application among the opioid-naïve in pre-admission clinics has not been studied. In addition to screening for potential risk factors for developing chronic opioid dependence prior to surgery, priority should be given to addressing psychosocial risk factors such as anxiety and fear that may lead to opioid dependence, as well as educating patients about the limited benefit of opioids with long-term use 12 . Long-term opioid use has been associated with poorer improvement in pain and function 13 . A clear treatment plan for opioid use in the acute postoperative phase should be developed that includes an agreement between the patient and the clinician for how opioids will be tapered and ceased. In addition, patients should be actively followed up within six to twelve weeks by telephone or, for those considered at high risk, in person. For those still taking opioids a revised planned opioid reduction strategy should be implemented along with referral for psychological therapies where required 14 .
Unintentional opioid deaths have been reported to occur most commonly due to multiple drug toxicity in younger (35 to 49 years) men who have been prescribed opioids for appropriate indications [15] [16] [17] . To avoid unintentional harm and deaths, it is imperative that all patients who initiate opioids post-surgery are educated about the importance of not taking opioids in combination with other medicines that depress the central nervous system 15, 18 or other pain relief medicines purchased over the counter. Also important is the opioid formulation used for acute pain. Only immediaterelease formulas should be prescribed and given at the lowest possible dose. Finally, patients should be aware of the potential for side-effects with opioids, such as constipation, nausea, vomiting, and cognitive impairment or opioidinduced ventilatory impairment, particularly in the elderly. Opioid-induced ventilatory impairment includes central respiratory depression, decreased levels of consciousness due to sedation, and upper airway obstruction. These can occur alone or in combination and increase the risk of harm. Opioid-induced ventilatory impairment can be further exacerbated by the co-administration of other medicines, particularly sedative medicines, highlighting the need to consider all therapies a patient is on when assessing risk 19 . Screening of patients prior to surgery and continuous monitoring of opioid use in the post-surgical phase is critical for finding opportunities to interrupt the path from acute opioid use to treat acute pain, to chronic opioid use to treat chronic pain.
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